Brief: Hansa Biopharma Q2 Net Income SEK -260.5 Million
22/07/2026 06:01
BRIEF-Hansa Biopharma Q2 Net Income SEK -260.5 Million Jul 22 (Reuters) - Hansa Biopharma Q2 adjusted EPS SEK -2.56.
- Q2 EBIT SEK -174.1 million
- Q2 cash & investments SEK 552.8 million
- Q2 revenue SEK 48.1 million
Recent news on Hansa Biopharma AB
See all newsBrief: Hansa Biopharma Q3 Rev Up At SEK 143 Mln
Sweden's Hansa Biopharma Q3 revenue surges on SERB license deal
Brief: Hansa Biopharma Q3 Net Income SEK -178.5 Million
Brief: Hansa Biopharma Announces Positive Idefirix Paes Results Presented In The High-Impact Clinical Trials Session At Asn Kidney Week
Brief: Hansa Biopharma Submits IND Application To FDA For HNSA-5487 In GBS